Sun Pharmaceuticals Industries Ltd, an integrated and speciality pharmaceutical company, announced that USFDA has granted approval for an Abbreviated New Drug Application (ANDA), a generic version of Boniva, Ibandronate Sodium Injection.
The company filed a press release with the BSE to announce the same.
Ibandronate Sodium Injection is indicated in the treatment of osteoporosis in post menopausal in women.
At 11:45 am, the shares of Sun Pharma were trading at Rs 487.20, up 5% on the Bombay Stock Exchange (BSE).
